Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Fresenius Medical Care AG & Co. KGaA is a medical care facilities business based in the US. Fresenius Medical Care AG-and-CoKGaA shares (FMS) are listed on the NYSE and all prices are listed in US Dollars. Fresenius Medical Care AG-and-CoKGaA employs 126,463 staff and has a market cap (total outstanding shares value) of USD$24.2 billion.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Casual investors
Latest market close | USD$41.56 |
---|---|
52-week range | USD$28.6891 - USD$45.7825 |
50-day moving average | USD$42.0836 |
200-day moving average | USD$42.467 |
Wall St. target price | USD$45.69 |
PE ratio | 11.1863 |
Dividend yield | USD$0.72 (1.74%) |
Earnings per share (TTM) | USD$3.692 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $41.56 from 2020-12-31
1 week (2021-01-12) | -1.21% |
---|---|
1 month (2020-12-22) | 0.82% |
3 months (2020-10-20) | 4.53% |
6 months (2020-07-20) | -5.76% |
1 year (2020-01-18) | N/A |
---|---|
2 years (2019-01-18) | 18.24% |
3 years (2018-01-19) | 55.75 |
5 years (2016-01-20) | 5.22% |
Valuing Fresenius Medical Care AG-and-CoKGaA stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fresenius Medical Care AG-and-CoKGaA's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fresenius Medical Care AG-and-CoKGaA's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Fresenius Medical Care AG-and-CoKGaA shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Fresenius Medical Care AG-and-CoKGaA's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7339. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fresenius Medical Care AG-and-CoKGaA's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Gross profit TTM | USD$5.4 billion |
---|---|
Return on assets TTM | 4.54% |
Return on equity TTM | 12.23% |
Profit margin | 7.37% |
Book value | $21.2925 |
Market capitalisation | USD$24.2 billion |
TTM: trailing 12 months
There are currently 379,918 Fresenius Medical Care AG-and-CoKGaA shares held short by investors – that's known as Fresenius Medical Care AG-and-CoKGaA's "short interest". This figure is 37.8% down from 611,194 last month.
There are a few different ways that this level of interest in shorting Fresenius Medical Care AG-and-CoKGaA shares can be evaluated.
Fresenius Medical Care AG-and-CoKGaA's "short interest ratio" (SIR) is the quantity of Fresenius Medical Care AG-and-CoKGaA shares currently shorted divided by the average quantity of Fresenius Medical Care AG-and-CoKGaA shares traded daily (recently around 140710.37037037). Fresenius Medical Care AG-and-CoKGaA's SIR currently stands at 2.7. In other words for every 100,000 Fresenius Medical Care AG-and-CoKGaA shares traded daily on the market, roughly 2700 shares are currently held short.
However Fresenius Medical Care AG-and-CoKGaA's short interest can also be evaluated against the total number of Fresenius Medical Care AG-and-CoKGaA shares, or, against the total number of tradable Fresenius Medical Care AG-and-CoKGaA shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fresenius Medical Care AG-and-CoKGaA's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Fresenius Medical Care AG-and-CoKGaA shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Fresenius Medical Care AG-and-CoKGaA shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Fresenius Medical Care AG-and-CoKGaA.
Find out more about how you can short Fresenius Medical Care AG-and-CoKGaA stock.
Dividend payout ratio: 26.94% of net profits
Recently Fresenius Medical Care AG-and-CoKGaA has paid out, on average, around 26.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fresenius Medical Care AG-and-CoKGaA shareholders could enjoy a 1.74% return on their shares, in the form of dividend payments. In Fresenius Medical Care AG-and-CoKGaA's case, that would currently equate to about $0.72 per share.
While Fresenius Medical Care AG-and-CoKGaA's payout ratio might seem fairly standard, it's worth remembering that Fresenius Medical Care AG-and-CoKGaA may be investing much of the rest of its net profits in future growth.
Fresenius Medical Care AG-and-CoKGaA's most recent dividend payout was on 11 September 2020. The latest dividend was paid out to all shareholders who bought their shares by 28 August 2020 (the "ex-dividend date").
Fresenius Medical Care AG-and-CoKGaA's shares were split on a 2:1 basis on 4 December 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Fresenius Medical Care AG-and-CoKGaA shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Fresenius Medical Care AG-and-CoKGaA shares which in turn could have impacted Fresenius Medical Care AG-and-CoKGaA's share price.
Over the last 12 months, Fresenius Medical Care AG-and-CoKGaA's shares have ranged in value from as little as $28.6891 up to $45.7825. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Fresenius Medical Care AG-and-CoKGaA's is 0.9204. This would suggest that Fresenius Medical Care AG-and-CoKGaA's shares are less volatile than average (for this exchange).
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides pharmacy services, vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2019, it operated 3,994 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.